PureTech Health Management
Management criteria checks 1/4
PureTech Health's CEO is Bharatt Chowrira, appointed in Apr 2024, has a tenure of less than a year. total yearly compensation is $2.49M, comprised of 23.1% salary and 76.9% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth €1.89M. The average tenure of the management team and the board of directors is 0.8 years and 8.2 years respectively.
Key information
Bharatt Chowrira
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 23.1% |
| CEO tenure | less than a year |
| CEO ownership | 0.4% |
| Management average tenure | less than a year |
| Board average tenure | 8.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$82m |
| Mar 31 2024 | n/a | n/a | -US$74m |
| Dec 31 2023 | US$2m | US$575k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$56m |
| Jun 30 2023 | n/a | n/a | -US$47m |
| Mar 31 2023 | n/a | n/a | -US$49m |
| Dec 31 2022 | US$988k | US$530k | -US$50m |
| Sep 30 2022 | n/a | n/a | -US$32m |
| Jun 30 2022 | n/a | n/a | -US$14m |
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$1m | US$500k | -US$61m |
Compensation vs Market: Bharatt's total compensation ($USD2.49M) is above average for companies of similar size in the German market ($USD1.01M).
Compensation vs Earnings: Bharatt's compensation has increased whilst the company is unprofitable.
CEO
Bharatt Chowrira (59 yo)
less than a year
Tenure
US$2,490,425
Compensation
Dr. Bharatt M. Chowrira, J. D. Ph. D. served as Chief Business and Operating Officer at PureTech Health plc. since January 2022 until 2024 and serves as its Chief Executive Officer from April 09, 2024 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | US$2.49m | 0.42% € 1.9m | |
| Founder | no data | US$4.74m | 3.35% € 15.0m | |
| Co-Founder & Non-Executive Director | no data | US$135.00k | 1.15% € 5.2m | |
| Co-Founder & President | less than a year | no data | no data | |
| Co-Founder & Senior Advisor | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Head of Communications & Investor Relations | no data | no data | no data | |
| General Counsel & Company Secretary | less than a year | no data | no data | |
| Senior Vice President of Human Resources | 4.4yrs | no data | no data | |
| Head of Oncology | 4.4yrs | no data | no data | |
| Head of Grants Management & Strategy | 4.4yrs | no data | no data |
0.8yrs
Average Tenure
56yo
Average Age
Experienced Management: 0VQ's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.8yrs | US$2.49m | 0.42% € 1.9m | |
| Founder | less than a year | US$4.74m | 3.35% € 15.0m | |
| Co-Founder & Non-Executive Director | no data | US$135.00k | 1.15% € 5.2m | |
| Co-Founder & Senior Advisor | no data | no data | no data | |
| Chair & Senior Independent Director | 10.9yrs | US$172.50k | 1.05% € 4.7m | |
| Independent Non-Executive Director | 15.9yrs | US$137.75k | 0.63% € 2.8m | |
| Board Advisor | 4.5yrs | US$68.94k | no data | |
| Advisor | 8.2yrs | no data | no data | |
| Advisor | 9.1yrs | no data | no data | |
| Senior Advisor | 8.9yrs | no data | no data | |
| Senior Advisor | no data | no data | no data | |
| Independent Non-Executive Director | 2.8yrs | US$135.00k | 0.016% € 72.1k |
8.2yrs
Average Tenure
74yo
Average Age
Experienced Board: 0VQ's board of directors are considered experienced (8.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 05:08 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PureTech Health plc is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Welford | Jefferies LLC |
| Thomas Smith | Leerink Partners LLC |
| Faisal Khurshid | Leerink Partners LLC |